(Q64188395)
Statements
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of lGIV-C as a Corticosteroid Sparing Agent in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis (English)
0 references
June 2015
0 references
February 2019
0 references
60
0 references
18 year
0 references
85 year
0 references